There is no fixed time limit for taking meloxicam. The FDA approves it for chronic conditions like osteoarthritis and rheumatoid arthritis, which means some people take it for months or even years. But the official guidance is to use the lowest effective dose for the shortest duration that meets your treatment goals, because the risks of serious side effects climb the longer you stay on it.
Short-Term vs. Long-Term Use
For acute pain from an injury or flare-up, most prescriptions run one to two weeks. There’s no hard rule here, but the principle is straightforward: once the pain resolves, you stop.
For chronic conditions, the picture is different. Meloxicam is FDA-approved as a maintenance medication for osteoarthritis and rheumatoid arthritis at 7.5 mg once daily, with the option to increase to 15 mg (the maximum daily dose for adults). People with these conditions often take it continuously because the underlying inflammation doesn’t go away. That’s considered appropriate, but it comes with trade-offs that grow over time.
How Risks Increase With Duration
Meloxicam carries an FDA black box warning for two categories of harm: cardiovascular events and gastrointestinal bleeding. Both risks rise the longer you take the drug.
On the cardiovascular side, meloxicam increases the chance of heart attack and stroke. This risk can appear as early as the first few weeks of daily use and continues climbing with time, particularly at higher doses.
The gastrointestinal numbers are more concrete. Roughly 1% of patients who take an NSAID like meloxicam for 3 to 6 months develop upper GI ulcers, serious bleeding, or a perforation in the stomach or intestinal wall. That figure doubles to 2% to 4% for patients treated for a full year, and the trend continues upward beyond that. These events can happen without any warning symptoms beforehand.
Several factors stack on top of duration to make GI bleeding more likely: being older, smoking, drinking alcohol, or taking meloxicam alongside blood thinners, corticosteroids, aspirin, or certain antidepressants (SSRIs).
What Long-Term Use Requires
If you and your doctor decide that staying on meloxicam is worth it for a chronic condition, ongoing monitoring becomes important. The FDA recommends periodic blood work, including a complete blood count and a chemistry panel, to catch problems before they become serious. Blood and urine tests can also flag early signs of kidney trouble, since NSAIDs can affect kidney function over time. If you notice signs of anemia like unusual fatigue, pallor, or shortness of breath, your hemoglobin levels should be checked.
The goal of these check-ins isn’t just to look for damage. They’re also an opportunity to reassess whether you still need the medication, whether the dose could be lowered, or whether a different approach to pain management might work.
Dose Limits That Apply at Any Duration
The maximum dose is 15 mg per day for adults, regardless of how long you’ve been on it or what formulation you use. Most people start at 7.5 mg, and many stay there. If you’re on dialysis, the ceiling drops to 7.5 mg daily. There’s no separate “long-term maintenance dose” that differs from the starting dose. The same range applies whether you’ve been taking it for a week or a year.
Stopping Meloxicam
Unlike some medications that require gradual tapering, meloxicam can be stopped abruptly without withdrawal symptoms or health risks. It’s not habit-forming, and your body won’t react negatively to sudden discontinuation. Some doctors may choose to lower the dose gradually simply as a matter of preference, but there’s no medical necessity for it. What you will likely notice is a return of pain and inflammation once the drug clears your system, which happens within a few days given its roughly 20-hour half-life.
Practical Takeaways for Duration
If you’re taking meloxicam for a short-term injury, a course of one to two weeks is typical, and you should stop when the pain resolves. If you’re managing a chronic condition like arthritis, indefinite use is common and FDA-approved, but it requires regular blood work and honest conversations about whether the benefit still outweighs the accumulating risk. The 3-to-6-month and one-year GI bleeding statistics are useful benchmarks to keep in mind as you and your doctor weigh that balance over time.